Management of Acute Ischaemic Stroke
Despite its dramatic incidence and prognosis, until few years ago, stroke was considered as the Cinderella of medicine. For both public and physicians, even neurologists, this pathology was unavoidable and untreatable. Fortunately, in the past decades this nihilistic attitude regarding stroke has been replaced by a more enthusiastic one. This is explained by research advances in pathophysiology of ischaemia and by the greater awareness of economic concerns about this pathology. The aim of experimental and clinical research is now to reduce mortality and stroke morbidity following stroke, and consequently to minimise costs.
KeywordsStroke Unit Restore Blood Flow European Cooperative Acute Stroke Study Ischaemic Penumbra Stroke Symptom Onset
Unable to display preview. Download preview PDF.
- 4.The European Ad Hoc Consensus Group (1996) European strategies for early intervention in stroke. Cerebrovasc Dis 6:351–324Google Scholar
- 6.Jørgensen HS, Nakayama U, Raaschou HA et al (1995) The effect of a stroke unit: reductions in mortality, discharge rate to nursing home, length of hospital stay, and cost. A community-based study. Stroke 26:1178–1182Google Scholar
- 7.The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 33:1581–1587Google Scholar